研究质量、年龄和地理因素对多囊卵巢综合征患病率的影响——系统综述与Meta分析
该系统综述与Meta分析检索PubMed和Embase截至2024年2月的多囊卵巢综合征研究,纳入88项研究(n=561287名女性)。鹿特丹标准下患病率最高,高质量研究显示鹿特丹、AE-PCOS和NIH标准的患病率分别为10.89%、10.61%和6.63%。NIH标准下成人患病率高于青少年(8.52% vs 4.44%,P=.01),但仅纳入高质量研究时差异减弱(7.25% vs 4.44%,P=.053)。
要点
- 高质量研究显示PCOS患病率鹿特丹标准10.89%、AE-PCOS标准10.61%、NIH标准6.63%。
- NIH标准下成人患病率8.52%高于青少年4.44%(P=.01),仅高质量研究时差异减弱(P=.053)。
- 仅高质量研究时NIH和鹿特丹标准下未见显著地区差异,非洲区域无可用研究。
核心结论
- 该系统综述与Meta分析显示不同诊断标准下PCOS患病率存在地区差异和年龄差异的趋势。
- 作者认为在进行此类Meta分析时应使用针对PCOS流行病学研究设计的工具(如PEP工具)考虑研究质量。
研究设计与样本
- 系统检索PubMed和Embase截至2024年2月的PCOS研究,纳入非选择人群的88项研究(n=561287名女性),来自7144条记录。
- 使用新开发的PCOS流行病学与表型(PEP)工具评估研究质量。
主要发现
- 鹿特丹标准下PCOS患病率最高,其次为雄激素过多与PCOS学会(AE-PCOS)标准,再次为美国国立卫生研究院(NIH)标准。
- 高质量研究显示鹿特丹、AE-PCOS和NIH标准的患病率分别为10.89%、10.61%和6.63%。
- 仅纳入高质量研究时,NIH标准下各地区患病率从东地中海区域(EMR)的5.72%到西太平洋区域(WPR)的6.90%,未见显著地区差异;鹿特丹标准下从东南亚的11.15%到EMR的9.12%,未见显著地区差异。
- AE-PCOS标准仅WPR区域有足够数据(6.9%);非洲区域无可用研究。
- NIH标准下成人患病率高于青少年(8.52% vs 4.44%;P=.01),仅纳入高质量研究时差异减弱(7.25% vs 4.44%;P=.053)。
关键数值与推荐
- 高质量研究(PEP工具评估)PCOS患病率:鹿特丹标准10.89%,AE-PCOS标准10.61%,NIH标准6.63%。
- 仅高质量研究NIH标准下地区患病率:EMR 5.72%,WPR 6.90%。
- 仅高质量研究鹿特丹标准下地区患病率:东南亚11.15%,EMR 9.12%。
- AE-PCOS标准仅WPR区域有足够数据,患病率6.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 鹿特丹和AE-PCOS标准下数据有限,限制年龄组比较。
- AE-PCOS标准仅WPR区域有足够数据,非洲区域无可用研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polycystic ovary syndrome (PCOS) is a highly prevalent disorder with substantial burden, yet global epidemiological data remains limited. OBJECTIVES: To estimate the PCOS prevalence globally. MATERIALS AND METHODS: We systematically searched PubMed and Embase for PCOS studies in unselected populations through February 2024. RESULTS: Our study included 88 studies (n = 561 287 women) from 7144 records. The highest PCOS prevalence was identified by the Rotterdam criteria, followed by the Androgen Excess and PCOS Society (AE-PCOS) and the National Institutes of Health (NIH). High-quality studies, as assessed using our newly developed PCOS Epidemiology and Phenotype (PEP) tool, indicated prevalences of 10.89%, 10.61%, and 6.63% using Rotterdam, AE-PCOS, and NIH, respectively. Considering only high-quality studies revealed no significant regional disparities using either NIH [ranging from 5.72% in the Eastern Mediterranean Region (EMR) to 6.90% in the Western Pacific Region (WPR)] or Rotterdam (ranging from 11.15% in South-East Asia to 9.12% in EMR). For AE-PCOS, sufficient data was available only for the WPR region (6.9%). No studies were available in the African Region. A higher PCOS prevalence was observed in adults than adolescents using NIH (8.52% vs 4.44%; P = .01), although the difference diminished when considering only high-quality studies (7.25% vs 4.44%; P = .053). Limited data restricted age-group comparisons using Rotterdam and AE-PCOS. CONCLUSION: This systematic review and meta-analysis reveals a trend toward regional variations and age differences across diagnostic criteria. The study results suggest considering study quality using instruments tailored for epidemiological studies in PCOS, such as the PEP tool, when carrying out these types of meta-analyses.
引用
- Amiri M, Hatoum S, Buyalos RP, et al. The Influence of Study Quality, Age, and Geographic Factors on PCOS Prevalence-A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2025. PMID: 39758024. doi:10.1210/clinem/dgae917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。